Podcasts about united neuroscience

Mei Mei Hu: Mei Mei is also CEO of United Neuroscience and a member of the executive committee of United Biomedical, Inc. She oversaw the launch of one of the first endobody vaccines in the world and the successful spin-out of three companies. Mei Mei was formerly a consultant at McKinsey & Company where she advised pharmaceutical companies on strategic, operational and organizational issues. Prior to that, Mei Mei was in the Securities group at Cravath, Swaine and Moore. Mei Mei is also co-founder of an investment and advisory group with active investments in real estate, energy and life sciences. She was named to Time 100 Next list, Fortune 40 under 40, and Young Global Leaders of World Economic Forum. She holds a B.A. from University of Pennsylvania and her J.D. from Harvard Law School. Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world's leaders on exponentially growing technologies. Peter Diamandis: As an entrepreneur, Diamandis has started over 20 companies in the areas of longevity, space, venture capital and education. He is cofounder of BOLD Capital Partners, a venture fund with $250M investing in exponential technologies, and co-founder and Vice Chairman of Celularity, Inc., a cellular therapeutics company. Diamandis is a New York Times Bestselling author of two books: Abundance – The Future Is Better Than You Think and BOLD – How to go Big, Create Wealth & Impact the World. His newest book in this series of exponential technologies—The Future is Faster Than You Think—was released in 2020. He earned degrees in molecular genetics and aerospace engineering from the MIT and holds an M.D. from Harvard Medical School. Diamandis’ favorite saying is “the best way to predict the future is to create it yourself.”

In this episode of the Effective Family Office Podcast, host Angelo Robles speaks with Dr. Peter H. Diamandis Founder and Executive Chairman of XPRIZE and Mei Mei Hu, Co-Founder of COVAXX and United Neuroscience. He shares his insights on entrepreneurs, technology, investing, and COVID-19.

In this episode of Bulletproof Radio, my guest is a chief … officer. (That’s not a typo—and I love it.) I talked with Lou Reese at the recent XPrize Visioneering conference. He loves all things vision and believes in creating environments in which we can reach our potential to be disruptive originals. He’s one the co-founders of United Neuroscience and a member of its board of directors. The company is a global team united against chronic disease with leaders in neurology, immunology, drug development at the helm. United Neuroscience is passionate about democratizing helath and delivering science-driven innovation that is accessible for all. Lou’s work focuses on hacking the immune system. It’s critical work.In 2018—for the first time in human history—“what killed us was things that our body made inside rather than things that were harmful coming from outside,” Lou explains. “The exogenous is no longer the primary enemy, the endogenous is the primary enemy.” Specifically, chronic illness is now our No. 1 killer.Listen on to learn about the ground-breaking solutions Lou and his team are developoing.Enjoy the show!

In this episode of Bulletproof Radio, my guest is a chief … officer. (That’s not a typo—and I love it.) I talked with Lou Reese at the recent XPrize Visioneering conference. He loves all things vision and believes in creating environments in which we can reach our potential to be disruptive originals. He’s one the co-founders of United Neuroscience and a member of its board of directors. The company is a global team united against chronic disease with leaders in neurology, immunology, drug development at the helm. United Neuroscience is passionate about democratizing helath and delivering science-driven innovation that is accessible for all. Lou’s work focuses on hacking the immune system. It’s critical work.In 2018—for the first time in human history—“what killed us was things that our body made inside rather than things that were harmful coming from outside,” Lou explains. “The exogenous is no longer the primary enemy, the endogenous is the primary enemy.” Specifically, chronic illness is now our No. 1 killer.Listen on to learn about the ground-breaking solutions Lou and his team are developoing.Enjoy the show!

On this week’s Tech Nation, Dr. Eric Schadt, the Founder & CEO of Sema4 talks about the explosion of personal medical information, and how it could work for us in the future. Then on Tech Nation Health, work on a vaccine to treat Alzheimer’s … and potentially prevent it. Dr. Ajay Verma, Chief Medical Officer of United Neuroscience tells us how and why it might work. Then Chief Correspondent Dr. Daniel Kraft talks about The Age Wave.

On this week’s Tech Nation, Dr. Eric Schadt, the Founder & CEO of Sema4 talks about the explosion of personal medical information, and how it could work for us in the future. Then on Tech Nation Health, work on a vaccine to treat Alzheimer’s … and potentially prevent it. Dr. Ajay Verma, Chief Medical Officer of United Neuroscience tells us how and why it might work. Then Chief Correspondent Dr. Daniel Kraft talks about The Age Wave.

Summary slide / text available at: http://www.gregoryschmidt.ca/writing/exponential-medicine-day-3-2018 Exponential Medicine, Day 3 - Cool Stuff Summary (Nov 6 2018) A collection of the most interesting ideas and slides of the day. ----- Sessions / Speakers Day Three Tuesday, November 6th Session 15: Exponential Organizations Salim Ismail Author, Exponential Organizations, Chairman, ExO Works, Board Member, XPRIZE, Global Ambassador, Singularity University Session 16: NeuroMedicine at the Frontier 16.1 Divya Chander MD PhD Neuroscience Chair, Singularity University 16.2 Matteo Lai CEO & Co-Founder, Empatica 16.3 Ariel Garten & Graeme Moffet Co-Founder, Muse 16.4 Mary Lou Jepsen PhD CEO & Founder, OpenWater 16.5 Eric C. Leuthardt MD Neurosurgeon, Director of the Center for Innovation in Neuroscience and Technology, Washington University in St. Louis Session 17: (im)Patient Innovators 17.1 Godfrey Nazareth President & CEO, X-Biomedical, Inc. 17.2 Mette Dyhrberg Founder & CEO, MyMee 17.3 Mariya Filipova Chief Innovation Officer, Anthem Session 18: Future of Work & Investing 18.1 Vinod Khosla Founder, Khosla Ventures 18.2 William Morris MD Associate Chief Information Officer, Cleveland Clinic Jennifer Radin, Deloitte Shawna Butler RN MBA Nurse Economist and EntrepreNURSE-in-Residence at Radboud University Medical Center Session 19: Care Reimagined; Connected, Digital and Virtualized 19.1 Jay Parkinson MD Founder & CEO, Sherpaa 19.2 Lara Jana MD Pediatrician, Associate Professor, Penn State 19.3 Walter Greenleaf AR & VR Thought Leader 19.4 Justin Barad MD Founder & CEO, OssoVR Session 20: Radical Interoperability John Mattison MD Chief Medical Information Officer, Kaiser Permanente John Nebeker MD MS Deputy CMIO, Veterans Health Administration Shannon Sartin Executive Director, Digital Services, U.S. Department of Health and Human Services Session 21: Lessons in Leadership Jason Tuschen & Jason Torey Former Navy SEALs, Randori Tech Session 22: Reshaping Pharma, Discovery & Trials 22.1 Noah Craft MD PhD CEO & Founder, Science 37 22.2 Mei Mei Hu CEO & Co-Founder, United Neuroscience 22.3 Onno Faber Founder, RDMD MEDy Awards

Christen and Michelle talk with Mei Mei Hu, CEO of United Neuroscience, about how being open to pivoting from your original plan can create a number of opportunities for an executive and their company, as well as how her executive team successfully manages a remote workforce spread across three continents. In a hilarious conversation about balancing professional and personal life, Hu also talks about how she ended up leading a spinout of her family’s life sciences business after a career in consulting, despite vowing to never be a part of the biotech world.

On this week’s Tech Nation, Dr. Eric Schadt, the Founder & CEO of Sema4 talks about the explosion of personal medical information, and how it could work for us in the future. Then on Tech Nation Health, work on a vaccine to treat Alzheimer’s … and potentially prevent it. Dr. Ajay Verma, Chief Medical Officer of United Neuroscience tells us how and why it might work. Then Chief Correspondent Dr. Daniel Kraft talks about The Age Wave.

On this week’s Tech Nation, Dr. Eric Schadt, the Founder & CEO of Sema4 talks about the explosion of personal medical information, and how it could work for us in the future. Then on Tech Nation Health, work on a vaccine to treat Alzheimer’s … and potentially prevent it. Dr. Ajay Verma, Chief Medical Officer of United Neuroscience tells us how and why it might work. Then Chief Correspondent Dr. Daniel Kraft talks about The Age Wave.

Lori La Bey host of Alzheimer's Speaks Radio talks with Dr. Ajay Verma, Chief Medical Officer at United Neuroscience.  They will discuss current therapies for dementia and the possible benefits of a vaccine vs. antibody approach for treatment.  They we also discuss how United Neuroscience vaccine is different from other vaccines and why he finds hope in their process. Last, they will wrap up with how families and those diagnosed can get involved in finding new treatments for dementia. Contact Dr. Ajay Verma: Website:  https://www.unitedneuroscience.com   For Additional Resources on Dementia and Caregiving Check out:              Alzheimer's Speaks https://www.alzheimersspeaks.com        Keynotes & Training  https://www.alzheimersspeaks.com/event-planners        Dementia Chats Videos  https://www.alzheimersspeaks.com/dementia-chats-webinar

Alzheimer's disease is the sixth leading cause of death and it continues to rise. Today it is costing the U.S. healthcare system $200 billion a year and there are no therapies that prevent, halt, or reverse the disease's progression. United Neuroscience is taking a new approach to the disease with its endobody vaccines, a class of synthetic biologics it is developing to treat Alzheimer's and other CNS conditions. We spoke to Ajay Verma, chief medical officer of United Neurosciences, about Alzheimer's, the company's platform technology, and the promise of enlisting the immune system in the fight against CNS diseases.